MatthewBull

Partner

Melbourne + 61.3.9101.6843

Matthew Bull has more than 20 years experience advising clients on all aspects of Australian competition and consumer law across a broad range of industries, including energy and resources, financial services, technology, and health.

Matt has particular experience advising on commercial transactions. He assists clients with achieving their commercial goals while managing competition issues arising in strategic collaborations such as joint ventures. Matt has significant experience obtaining clearance from the ACCC (Australian Competition & Consumer Commission) for complex mergers and acquisitions, including navigating Phase 2 merger reviews and developing solutions to address competition concerns.

Matt regularly advises clients on matters involving infrastructure such as ports, airports, railway networks, gas pipelines, and electricity networks. He has a deep understanding of economic regulation and the issues facing access seekers/providers, including advising clients in access disputes, price arbitrations, and price reviews by the AER (Australian Energy Regulator), QCA (Queensland Competition Authority), and ERA (Energy Resources of Australia).

Matt also represents clients during ACCC market inquiries and market studies. He not only assists clients in complying with their obligations to produce material to the ACCC, but also helps clients draft persuasive submissions. He represents clients during examinations conducted by the ACCC as part of these market inquiries.

Matt advises clients in enforcement and litigation matters. He is experienced in responding to informal investigations as well as compulsory notices to produce documents.

Matt is a member of the Law Council of Australia's Competition and Consumer Committee, the leading competition policy body in Australia, and co-edited the market definition chapter in the leading CCH textbook Australian Competition Law.

Experience

  • Westpac Banking acquires HealthPointJones Day advised Westpac Banking Corporation in the acquisition of HealthPoint, an electronic health claims processing business.
  • Intelligent Monitoring Group acquires ADT security businessJones Day advised ASX-listed Intelligent Monitoring Group Ltd on its A$45 million acquisition of the ADT security monitoring business in Australia and New Zealand (through the acquisition of Tyco Australia Group Pty Ltd) and the associated A$80 million acquisition finance facility and A$17 million equity raising undertaken by accelerated entitlement offer and a top-up placement.
  • Parker Hannifin's recommended all cash acquisition of Meggitt PLCJones Day acted as counsel to Parker Hannifin Corporation in the £6.3 billion acquisition of Meggitt plc, a leading international company headquartered in Coventry, United Kingdom, specializing in high performance components and subsystems for the aerospace, defense and selected energy markets.
  • Celgene makes joint application to ACCC for statutory immunity with generic suppliersJones Day advised Celgene Corporation and Celgene Pty Limited on a joint application with two generic suppliers, Juno Pharmaceuticals and Natco Pharma, to the Australian Competition and Consumer Commission ("ACCC") for statutory immunity.
  • Andrew Dzurak and Allectus Capital create leading quantum computing company, Diraq Pty LtdJones Day acted for Professor Andrew Dzurak and Allectus Capital, in the creation of a leading quantum computing company, Diraq Pty Ltd (formerly, SiMOS Newco Pty Ltd) whose founding shareholders consist of the University of New South Wales, Allectus Capital and Professor Dzurak.
  • LGIAsuper acquires Suncorp’s superannuation businessJones Day advised LGIAsuper in the $45 million acquisition of Suncorp’s superannuation business, through the acquisition of Suncorp Portfolio Services Limited (SPSL).
  • Hornblower Group acquires Journey BeyondJones Day advised Hornblower Group, Inc. in its acquisition of Australia's leading experiential travel group, Journey Beyond.
  • The Duchossois Group sells The Chamberlain Group LLC to BlackstoneJones Day advised The Duchossois Group, Inc. in the sale of The Chamberlain Group LLC, a global leader in smart access solutions, to private equity funds managed by Blackstone.
  • Cooper Tire & Rubber sold to The Goodyear Tire & Rubber Company for approximately $2.5 billion enterprise valueJones Day advised Cooper Tire & Rubber Company in its $2.5 billion sale to The Goodyear Tire & Rubber Company.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • The following represents experience acquired prior to joining Jones Day.

    Advised BHP Billiton on competition and regulatory issues involving access to significant gas, port, and rail infrastructure.

    Advised Santos on a wide range of matters, including obtaining ACCC clearance for its acquisition of Eastern Star Gas, obtaining ACCC authorization for oil arrangements in the Surat Basin, and providing advice on various joint venture arrangements (including the Gladstone LNG project).

    Advised Suncorp on various matters, including its sale of a 90% interest in Capital Smart and ACM Parts to AMA and the sale of its life insurance business to TAL Daichi Life.

    Advised IFM on a variety of matters, including its $5 billion acquisition of Port Botany and Port Kembla in Sydney, its $16 billion acquisition of electricity business Ausgrid, its bid for the Port of Melbourne, bids for toll road businesses in Brisbane and Sydney, and ACCC proceedings against NSW Ports.

    Represented Murray Goulburn during court proceedings brought by the ACCC in relation to milk pricing, including negotiating the settlement of the matter.

    Advised clients during public reviews and inquiries conducted by the ACCC into digital platforms, wine grapes, gas supply, and the dairy industry.